A comprehensive analysis to reveal the underlying molecular mechanisms of natural killer cell in thyroid carcinoma

Xiaoqiong Li1, Kejiang Wang2, Jiaxin Liu2

  • 1The Department of Experimental Medicine, Meishan City People's Hospital, No. 288, South Fourth Section, Dongpo Avenue, Meishan, 620000, Sichuan, China. 18784448010@163.com.

Discover Oncology
|January 14, 2025
PubMed
Abstract

Insights

Natural killer (NK) cells are crucial for thyroid carcinoma (THCA) immune surveillance. This study identified key genes and pathways, offering new diagnostic and therapeutic strategies for THCA.

Area of Science:

  • Endocrinology
  • Immunology
  • Oncology

Background:

  • Thyroid carcinoma (THCA) is the most prevalent endocrine malignancy.
  • Natural killer (NK) cells are vital for anti-tumor immune surveillance.
  • Understanding NK cell roles in THCA is critical for disease management.

Purpose of the Study:

  • To investigate the molecular mechanisms of NK cells in THCA.
  • To identify potential diagnostic biomarkers and therapeutic targets for THCA.

Main Methods:

  • Utilized public databases for THCA and NK cell data.
  • Employed limma, WGCNA, and singleR for hub gene identification.
  • Constructed gene regulatory networks (mRNA-miRNA-lncRNA, TF) and predicted drugs.

Main Results:

  • NK cell infiltration was elevated in THCA tissues.
  • CTSC, FN1, SLC34A2, and TMSB4X were identified as hub genes.
  • Identified potential diagnostic biomarkers, regulatory networks, and NK cell-related drugs (belinostat, vorinostat).

Conclusions:

  • Key signaling pathways, molecules, and drugs were identified for THCA.
  • Findings provide research directions for THCA diagnostics and therapeutics.